Aspartic protease inhibitors as potential anti-Candida albicans drugs: impacts on fungal biology, virulence and pathogenesis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Medicinal Chemistry

• Publication date

  2011-05-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/092986711795843182PMID 21568917
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunity to fungal infections

  2011cited by this paper
• Aspartic Proteases of Human Pathogenic Fungi are Prospective Targets for the Generation of Novel and Effective Antifungal Inhibitors

  2011cited by this paper
• Protease expression by microorganisms and its relevance to crucial physiological/pathological events.

  2011cited by this paper
• Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds.

  2010cited by this paper
• Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression

  2010cited by this paper
• Effect of serine-type protease of Candida spp. isolated from linear gingival erythema of HIV-positive children: critical factors in the colonization.

  2010cited by this paper
• Aspartic Peptidase Inhibitors as Potential Bioactive Pharmacological Compounds Against Human Fungal Pathogens

  2010cited by this paper
• Proteolytic Cleavage of Covalently Linked Cell Wall Proteins by Candida albicans Sap9 and Sap10

  2010cited by this paper
• Antifungal drug resistance of oral fungi

  2010cited by this paper
• Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes

  2010cited by this paper
• Oropharyngeal candidiasis in the era of antiretroviral therapy.

  2010cited by this paper
• Concentration-dependent effects and intracellular accumulation of HIV protease inhibitors in cultured CD4 T cells and primary human lymphocytes.

  2010cited by this paper
• HIV protease inhibitors differentially inhibit adhesion of Candida albicans to acrylic surfaces

  2010cited by this paper
• Invasive Fungal Infections in the ICU

  2010cited by this paper
• Pathogenesis of invasive candidiasis

  2010cited by this paper
• Multiple effects of amprenavir against Candida albicans.

  2010influential reference
• Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape.

  2010cited by this paper
• Candidosis, a new challenge.

  2010cited by this paper
• Candida spp. bloodstream infection: influence of antifungal treatment on outcome.

  2010cited by this paper
• Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections.

  2010cited by this paper
• The Inflammatory Response Induced by Aspartic Proteases of Candida albicans Is Independent of Proteolytic Activity

  2010cited by this paper
• Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.

  2009cited by this paper
• CANDIDA ALBICANS AND NON-ALBICANS BLOODSTREAM INFECTIONS IN ADULT AND PEDIATRIC PATIENTS: COMPARISON OF MORTALITY AND COSTS

  2009cited by this paper
• Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review

  2009cited by this paper
• Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases.

  2009cited by this paper
• The yeast Candida albicans evades human complement attack by secretion of aspartic proteases.

  2009cited by this paper
• Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

  2009cited by this paper
• The Glycosylphosphatidylinositol-Anchored Protease Sap9 Modulates the Interaction of Candida albicans with Human Neutrophils

  2009cited by this paper
• Phylogeny and evolution of the aspartyl protease family from clinically relevant Candida species.

  2009cited by this paper
• Lipid signaling in pathogenic fungi.

  2009cited by this paper
• Targeting virulence: a new paradigm for antifungals.

  2009cited by this paper
• Risk factors for gastrointestinal adverse events in HIV treated and untreated patients.

  2009cited by this paper
• Toxicity of HIV protease inhibitors: clinical considerations

  2008cited by this paper
• Epidemiology of invasive fungal infection.

  2008cited by this paper
• Secreted proteins of Candida albicans.

  2008cited by this paper
• Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act.

  2008cited by this paper
• Tipranavir exhibits different effects on opportunistic pathogenic fungi.

  2008influential reference
• X‐ray structures of Sap1 and Sap5: Structural comparison of the secreted aspartic proteinases from Candida albicans

  2008cited by this paper
• Changing epidemiology of systemic fungal infections.

  2008cited by this paper
• Current challenges in the management of invasive fungal infections

  2008cited by this paper
• The epidemiology of sepsis.

  2008cited by this paper
• Indinavir influences biological function of dendritic cells and stimulates antifungal immunity

  2008cited by this paper
• New and emerging treatments for fungal infections.

  2008cited by this paper
• Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis.

  2008influential reference
• Cathepsin D--many functions of one aspartic protease.

  2008cited by this paper
• Secreted aspartic proteases are not required for invasion of reconstituted human epithelia by Candida albicans.

  2008cited by this paper
• Candida glabrata fungaemia in intensive care units.

  2008cited by this paper
• Beneficial Effects of HIV Peptidase Inhibitors on Fonsecaea pedrosoi: Promising Compounds to Arrest Key Fungal Biological Processes and Virulence

  2008cited by this paper
• Design of Potent Aspartic Protease Inhibitors to Treat Various Diseases

  2008cited by this paper
• Update on new antifungal therapy.

  2007cited by this paper
• Morphogenesis in Candida albicans.

  2007cited by this paper
• Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells

  2007cited by this paper
• The role of secreted aspartyl proteinases in Candida albicans keratitis.

  2007cited by this paper
• Mucosal Tissue Invasion by Candida albicans Is Associated with E-Cadherin Degradation, Mediated by Transcription Factor Rim101p and Protease Sap5p

  2007cited by this paper
• The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A

  2007cited by this paper
• Genomics and the development of new diagnostics and anti-Candida drugs.

  2007cited by this paper
• Candida albicans biofilms produce more secreted aspartyl protease than the planktonic cells.

  2007cited by this paper
• Recent advances in antifungal agents.

  2007cited by this paper
• Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

  2007cited by this paper
• Effect of suramin on the human pathogen Candida albicans: implications on the fungal development and virulence.

  2007cited by this paper
• Flocculation, adhesion and biofilm formation in yeasts

  2006cited by this paper
• Invasive Fungal Pathogens: Current Epidemiological Trends

  2006influential reference
• Development of inhibitors of the aspartyl protease renin for the treatment of hypertension.

  2006cited by this paper
• Secretory aspartyl peptidase activity from mycelia of the human fungal pathogen Fonsecaea pedrosoi: effect of HIV aspartyl proteolytic inhibitors.

  2006cited by this paper
• Detection of HIV Protease Inhibitors in Alveolar Epithelial Lining Fluid: Relevance for Modulation of Pneumocystis Infection in the Course of HAART

  2006cited by this paper
• Glycosylphosphatidylinositol-anchored Proteases of Candida albicans Target Proteins Necessary for Both Cellular Processes and Host-Pathogen Interactions*

  2006influential reference
• Morphogenesis and cell cycle progression in Candida albicans.

  2006cited by this paper
• Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers

  2006cited by this paper
• Indinavir-treated Cryptococcus neoformans promotes an efficient antifungal immune response in immunosuppressed hosts.

  2006cited by this paper
• Candidaemia in Europe: epidemiology and resistance.

  2006cited by this paper
• Current status and future of antifungal therapy for systemic mycoses.

  2006cited by this paper
• The changing epidemiology of invasive fungal infections: new threats.

  2006cited by this paper
• Secretion of serine peptidase by a clinical strain of Candida albicans: influence of growth conditions and cleavage of human serum proteins and extracellular matrix components.

  2006cited by this paper
• Candidiasis visualised by proteinase-directed immunofluorescence

  2005cited by this paper
• Hydrolytic enzymes as virulence factors of Candida albicans

  2005cited by this paper
• Profile of Candida albicans-Secreted Aspartic Proteinase Elicited during Vaginal Infection

  2005cited by this paper
• Interaction of pathogenic fungi with host cells: Molecular and cellular approaches.

  2005cited by this paper
• Candida albicans-Secreted Aspartic Proteinases Modify the Epithelial Cytokine Response in an In Vitro Model of Vaginal Candidiasis

  2005cited by this paper
• Empirical Anti-Candida Therapy among Selected Patients in the Intensive Care Unit: A Cost-Effectiveness Analysis

  2005cited by this paper
• Protease inhibitors in the clinic.

  2005cited by this paper
• An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART

  2005cited by this paper
• Cellular mechanisms of insulin resistance, lipodystrophy and atherosclerosis induced by HIV protease inhibitors.

  2005cited by this paper
• Journal of Antimicrobial Chemotherapy

  2005cited by this paper
• Candida guilliermondii isolated from HIV-infected human secretes a 50 kDa serine proteinase that cleaves a broad spectrum of proteinaceous substrates.

  2005cited by this paper
• Influence of indinavir on virulence and growth of Cryptococcus neoformans.

  2005cited by this paper
• The immune response to fungal infections

  2005cited by this paper
• Induction of SAP7 Correlates with Virulence in an Intravenous Infection Model of Candidiasis but Not in a Vaginal Infection Model in Mice

  2005cited by this paper
• Combination Treatment of Invasive Fungal Infections

  2005cited by this paper
• The distinct morphogenic states of Candida albicans.

  2004cited by this paper
• Candida morphogenesis and host-pathogen interactions.

  2004cited by this paper
• Differential Recovery of Candida Species from Subgingival Sites in Human Immunodeficiency Virus-Positive and Healthy Children from Rio de Janeiro, Brazil

  2004cited by this paper
• Interaction between saquinavir and antimycotic drugs on C. albicans and C. neoformans strains.

  2004cited by this paper
• Candida albicans Biofilms: a Developmental State Associated With Specific and Stable Gene Expression Patterns

  2004cited by this paper
• Peptidomimetic inhibitors of HIV protease.

  2004cited by this paper
• The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans.

  2004cited by this paper
• Candida albicans proteinases and host/pathogen interactions

  2004influential reference
• Candida Infections of Medical Devices

  2004cited by this paper
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• Social support and quality of life over time among adults living with HIV in the HAART era.

  2004cited by this paper
• Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

  2004cited by this paper

• Impact of high SAP2 expression on the invasion and adhesion abilities of Candida albicans in vaginal epithelial cells.

  2025cites this paper
• Impact of pH, Temperature and Exogenous Proteins on Aspartic Peptidase Secretion in Candida auris and the Candida haemulonii Species Complex

  2025cites this paper
• Saps1–3 Antigens in Candida albicans: Differential Modulation Following Exposure to Soluble Proteins, Mammalian Cells, and Infection in Mice

  2024cites this paper
• Molecular docking study of Thymus vulgaris phytochemical against Candida albicans secreted aspartyl protease 5

  2024cites this paper
• Secreted aspartyl proteases family: a perspective review on the regulation of fungal pathogenesis.

  2023cites this paper
• Bis 1, 2, 3‐ Triazoles Linked Deoxybenzoin Hybrids as Antimicrobial Agents: Synthesis, In Vitro and In Silico Screening

  2023cites this paper
• In vitro and In silico Studies of Kayu Raja (Cassia fistula L.) Leaves Extract as Potential Antifungal Agent Against Candida albicans

  2023cites this paper
• Peptidases: promising antifungal targets of the human fungal pathogen, Cryptococcus neoformans

  2022cites this paper
• Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from Candida albicans—In Silico, In Vitro and In Vivo Approaches

  2021cites this paper
• Superparamagnetic Cobalt Nanoparticles in Hyperbranched Polyester Polyol matrix with Anti-Protease Activity

  2021cites this paper
• References

  2021cites this paper
• Protease Inhibitors Purified from the Canola Meal Extracts of Two Genetically Diverse Genotypes Exhibit Antidiabetic and Antihypertension Properties

  2021cites this paper
• Insights into the Role of Tick Salivary Protease Inhibitors during Ectoparasite–Host Crosstalk

  2021cites this paper
• Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interaction

  2020cites this paper
• NLRP3 Inflammasome and Inflammatory Diseases

  2020cites this paper
• The serine peptidase inhibitor TPCK induces several morphophysiological changes in the opportunistic fungal pathogen Candida parapsilosis sensu stricto.

  2019cites this paper
• Upregulation of secreted aspartyl proteinase genes of fluconazole-sensitive Candida albicans isolates

  2019cites this paper
• Investigating Common Pathogenic Mechanisms between Homo sapiens and Different Strains of Candida albicans for Drug Design: Systems Biology Approach via Two-Sided NGS Data Identification

  2019cites this paper
• Molecular analysis of candida albicans Secreted Aspartyl Proteinase 3 (SAP3) Indonesian isolate

  2018cites this paper
• Comparison of the Effect of Amino Acids and Their Derivatives on the Growth of Some Dermatophytes: An In Vitro Study

  2018cites this paper
• Scedosporium apiospermum, Scedosporium aurantiacum, Scedosporium minutisporum and Lomentospora prolificans: a comparative study of surface molecules produced by conidial and germinated conidial cells

  2018cites this paper
• Phytochemical Profile and Anti-lipase Activity of Balkan Endemic Jurinea tzar-ferdinandii

  2018cites this paper
• Secreted aspartyl proteinase (PbSap) contributes to the virulence of Paracoccidioides brasiliensis infection

  2018cites this paper
• Bioactivity Assessment of Indian Origin—Mangrove Actinobacteria against Candida albicans

  2018cites this paper
• Partial Purification, Characterization, and Application of Extracellular Aspartic Protease from Lactobacillus casei WSP in Producing the Bioactive Peptides with Antibacterial and Antioxidant Activity

  2018cites this paper
• Roles of Candida albicans aspartic proteases in host-pathogen interactions

  2017cites this paper
• HIV Aspartic Peptidase Inhibitors Modulate Surface Molecules and Enzyme Activities Involved with Physiopathological Events in Fonsecaea pedrosoi

  2017influential citation
• The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi.

  2017cites this paper
• Synergistic Antifungal Effect of Fluconazole Combined with Licofelone against Resistant Candida albicans

  2017cites this paper
• The HIV aspartyl protease inhibitor ritonavir impairs planktonic growth, biofilm formation and proteolytic activity in Trichosporon spp.

  2017influential citation
• Direct electric current modifies important cellular aspects and ultrastructure features of Candida albicans yeasts: Influence of doses and polarities

  2017cites this paper
• Protease Inhibitors as Ad-hoc Antibiotics

  2016cites this paper
• Fungal Enolase, β-Tubulin, and Chitin Are Detected in Brain Tissue from Alzheimer’s Disease Patients

  2016cites this paper
• Susceptibility of Candida albicans to New Synthetic Sulfone Derivatives

  2015cites this paper
• Phenotypic Characteristics Associated with Virulence of Clinical Isolates from the Sporothrix Complex

  2015cites this paper
• New strategies for local treatment of vaginal infections.

  2015cites this paper
• Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans

  2015cites this paper
• Role of SAP7-10 and Morphological Regulators (EFG1, CPH1) in Candida albicans' Hypha Formation and Adhesion to Colorectal Carcinoma Caco-2.

  2015cites this paper
• Sulfone derivatives reduce growth, adhesion and aspartic protease SAP2 gene expression

  2014cites this paper
• 1,10-Phenanthroline Inhibits the Metallopeptidase Secreted by Phialophora verrucosa and Modulates its Growth, Morphology and Differentiation

  2014influential citation
• Screening of Compounds from an FDA-Approved Drug Library for the Ability to Inhibit Aspartic Protease Secretion from the Pathogenic Yeast Candida albicans

  2014cites this paper
• Gull fra havets sølv

  2014cites this paper
• The in vitro effects of new D186 dendrimer on virulence factors of Candida albicans

  2014cites this paper
• Sulfone derivatives reduce growth, adhesion and aspartic protease SAP2 gene expression

  2014cites this paper
• On the search for multitarget inhibitors for BACE‐1 and other pharmacological targets of Alzheimer's Disease

  2014influential citation
• Decoding the Anti-Trypanosoma cruzi Action of HIV Peptidase Inhibitors Using Epimastigotes as a Model

  2014cites this paper
• Evaluation of efficacy, pharmacokinetics and tolerability of peptidomimetic aspartic proteinase inhibitors as cream formulation in experimental vaginal candidiasis

  2014cites this paper
• On the active site protonation state in aspartic proteases: implications for drug design.

  2013cites this paper
• Aspartic Peptidases of Human Pathogenic Trypanosomatids: Perspectives and Trends for Chemotherapy

  2013cites this paper
• Phenotypical properties associated with virulence from clinical isolates belonging to the Candida parapsilosis complex.

  2013cites this paper
• Efficient Screening of Marine Extracts for Protease Inhibitors by Combining FRET Based Activity Assays and Surface Plasmon Resonance Spectroscopy Based Binding Assays

  2013cites this paper
• Aspartic Proteolytic Inhibitors Induce Cellular and Biochemical Alterations in Fungal Cells

  2013cites this paper
• Allosteric inhibition of BACE1 by an exosite-binding antibody.

  2013cites this paper
• Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans.

  2013cites this paper
• Candida and candidiasis in HIV-infected patients: where commensalism, opportunistic behavior and frank pathogenicity lose their borders

  2012cites this paper
• Aspartic protease inhibitors: effective drugs against the human fungal pathogen Candida albicans.

  2012cites this paper
• Cellular characterisation of Candida tropicalis presenting fluconazole-related trailing growth.

  2012cites this paper
• Microbial and fungal protease inhibitors—current and potential applications

  2012cites this paper
• A peptide derived from the highly conserved protein GAPDH is involved in tissue protection by different antifungal strategies and epithelial immunomodulation

  2012cites this paper
• Substrate-Specific Gene Expression in Batrachochytrium dendrobatidis, the Chytrid Pathogen of Amphibians

  2012cites this paper
• Antimicrobial action of chelating agents: repercussions on the microorganism development, virulence and pathogenesis.

  2012cites this paper
• Studies on physicochemical and biological properties of protease inhibitor from edible mushroom Pleurotus floridanus

  2012cites this paper
• Jurnal Kimia Sains dan Aplikasi

  year unknowncites this paper